105 related articles for article (PubMed ID: 2619427)
1. Pharmacokinetics of dipyridamole-beta-cyclodextrin complex in dogs.
Stracciari GL; Malvisi J; Anfossi P; Fregnan GB
Arch Int Pharmacodyn Ther; 1989; 300():7-13. PubMed ID: 2619427
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of dipyridamole-beta-cyclodextrin complex in healthy volunteers after single and multiple doses.
Ricevuti G; Mazzone A; Pasotti D; Uccelli E; Pasquali F; Gazzani G; Fregnan GB
Eur J Drug Metab Pharmacokinet; 1991; 16(3):197-201. PubMed ID: 1814737
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of specific biological activity of dipyridamole by complexation with beta-cyclodextrin.
Fregnan GB; Bertè F
Pharmacology; 1990; 40(2):96-102. PubMed ID: 2345776
[TBL] [Abstract][Full Text] [Related]
4. Beta- cyclodextrin complexation improves absorption and gastric tolerability of piroxicam.
Cadel S; Bongrani S
Acta Physiol Hung; 1990; 75 Suppl():45-6. PubMed ID: 2371898
[No Abstract] [Full Text] [Related]
5. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
Zuo Z; Tam YK; Diakur J; Wiebe LI
J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
[TBL] [Abstract][Full Text] [Related]
6. Production and investigating of tablets containing furosemide and beta-cyclodextrin.
Kata M; Haragh L; Pintye-Hódi K
Acta Pharm Hung; 1990 Jan; 60(1):40-5. PubMed ID: 2327256
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vitro-in vivo evaluation of none gastric resident dipyridamole (DIP) sustained-release pellets with enhanced bioavailability.
Xu L; Luo Y; Feng J; Xu M; Tao X; He H; Tang X
Int J Pharm; 2012 Jan; 422(1-2):9-16. PubMed ID: 22001837
[TBL] [Abstract][Full Text] [Related]
8. Improvement in percutaneous absorption of prednisolone by beta- and gamma-cyclodextrin complexations.
Uekama K; Arimori K; Sakai A; Masaki K; Irie T; Otagiri M
Chem Pharm Bull (Tokyo); 1987 Jul; 35(7):2910-3. PubMed ID: 3677241
[No Abstract] [Full Text] [Related]
9. Supermolecular inclusion of piroxicam with beta-cyclodextrin: pharmacokinetic properties in man.
Woodcock BG; Acerbi D; Merz PG; Rietbrock S; Rietbrock N
Eur J Rheumatol Inflamm; 1993; 12(4):12-28. PubMed ID: 7805700
[TBL] [Abstract][Full Text] [Related]
10. Absorption, distribution, excretion and metabolism of orally administered 14C-beta-cyclodextrin in rat.
Gerlóczy A; Fónagy A; Keresztes P; Perlaky L; Szejtli J
Arzneimittelforschung; 1985; 35(7):1042-7. PubMed ID: 4052138
[TBL] [Abstract][Full Text] [Related]
11. Design and in vivo testing of 17 beta-estradiol-HP beta CD sublingual tablets.
Fridriksdóttir H; Loftsson T; Gudmundsson JA; Bjarnason GJ; Kjeld M; Thorsteinsson T
Pharmazie; 1996 Jan; 51(1):39-42. PubMed ID: 8999433
[TBL] [Abstract][Full Text] [Related]
12. Preparation of a phenytoin beta-cyclodextrin complex and evaluation of a suspension and a tablet dosage form prepared from the complex.
Hegde RP; Rhodes CT
Pharm Acta Helv; 1985; 60(2):53-7. PubMed ID: 3991746
[No Abstract] [Full Text] [Related]
13. [Application of beta-cyclodextrin during direct pressing of tablets].
Szabóné RP; Pintyéné HK; Kun L; Miseta M; Selmeczi B
Acta Pharm Hung; 1989 May; 59(3):99-107. PubMed ID: 2763849
[TBL] [Abstract][Full Text] [Related]
14. Determination of hydroxypropyl-beta-cyclodextrin in plasma and urine by size-exclusion chromatography with post-column complexation.
Szathmary SC
J Chromatogr; 1989 Jan; 487(1):99-105. PubMed ID: 2715279
[TBL] [Abstract][Full Text] [Related]
15. Development and in vivo evaluation of buccal tablets prepared using danazol-sulfobutylether 7 beta-cyclodextrin (SBE 7) complexes.
Jain AC; Aungst BJ; Adeyeye MC
J Pharm Sci; 2002 Jul; 91(7):1659-68. PubMed ID: 12115827
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC.
Kou W; Cai C; Xu S; Wang H; Liu J; Yang D; Zhang T
Int J Pharm; 2011 May; 409(1-2):75-80. PubMed ID: 21371541
[TBL] [Abstract][Full Text] [Related]
17. Effects of 2-hydroxypropyl-beta-cyclodextrin on pharmacokinetics of digoxin in rabbits and humans.
He ZG; Li YS; Zhang TH; Tang X; Zhao C; Zhang RH
Pharmazie; 2004 Mar; 59(3):200-2. PubMed ID: 15074593
[TBL] [Abstract][Full Text] [Related]
18. Disposition of [14C]gamma-cyclodextrin in germ-free and conventional rats.
De Bie AT; Van Ommen B; Bär A
Regul Toxicol Pharmacol; 1998 Apr; 27(2):150-8. PubMed ID: 9671569
[TBL] [Abstract][Full Text] [Related]
19. Availability of phenindione-beta-cyclodextrin inclusion complex.
Tous SS; el-Sayed AM; el-Harras SA; Jun HW
Pharmazie; 1992 May; 47(5):365-8. PubMed ID: 1409827
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of bioavailability of cinnarizine from its beta-cyclodextrin complex on oral administration with DL-phenylalanine as a competing agent.
Tokumura T; Tsushima Y; Kayano M; Machida Y; Nagai T
J Pharm Sci; 1985 Apr; 74(4):496-7. PubMed ID: 3999017
[No Abstract] [Full Text] [Related]
[Next] [New Search]
